A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy

Dulguun Amgalan(Albert Einstein College of Medicine), Richard N. Kitsis(Albert Einstein College of Medicine), Luis Rivera Sanchez(Albert Einstein College of Medicine), Rachel B. Hazan(Albert Einstein College of Medicine), Xiaotong F. Jia(Albert Einstein College of Medicine), Felix G. Liang(Albert Einstein College of Medicine), John S. Condeelis(Albert Einstein College of Medicine), Kelly Mitchell(Albert Einstein College of Medicine), Gaetano Santulli(Albert Einstein College of Medicine), Lorrie A. Kirshenbaum(University of Manitoba), Evripidis Gavathiotis(Albert Einstein College of Medicine), Victoria Margulets(Technion – Israel Institute of Technology), Marco Scarlata(Albert Einstein College of Medicine), Randall T. Peterson(University of Utah), George S. Karagiannis(Albert Einstein College of Medicine), Andrea López(Albert Einstein College of Medicine), Ryan Pekson(Albert Einstein College of Medicine), Ulrich Steidl(Albert Einstein College of Medicine), Victor M. Paulino(Albert Einstein College of Medicine), Aarti Asnani(Beth Israel Deaconess Medical Center), Swathi-Rao Narayanagari(Albert Einstein College of Medicine), Mounica Yanamandala(Brigham and Women's Hospital), Yun Chen(Sun Yat-sen University), Jaehoon Lee(KT&G (South Korea)), Thomas P. Garner(Albert Einstein College of Medicine), J. Jose Corbalan(Research & Development Institute), Huizhi Liang(Albert Einstein College of Medicine), Maja H. Oktay(Albert Einstein College of Medicine)

Nature Cancer

March 2, 2020

Cited by 123

|Nature Biotechnology|2013|3k

|Nature|2015|1.7k

|Nature Reviews Drug Discovery|2005|1.4k

|The Journal of Cell Biology|2000|911

|Biology of Reproduction|2004|665

Related Papers